Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences
MJH Life Sciences

SUBSCRIBE: Print / eNewsletter

Leah Lawrence

Can Menopausal Hormone Therapy Increase the Risk of Breast Cancer?

August 30, 2019
  • Leah Lawrence

Researchers analyzed data from 108,647 postmenopausal women diagnosed with breast cancer to see if there was an increased risk of the disease for those who used menopausal hormone therapy.

  • READ >>

Half of NCI Cancer Center Physician Directors Received Industry Payments in 2017

August 6, 2019
  • Leah Lawrence

In 2017, about half of physician directors at National Cancer Institute cancer centers received payments related to research, while a quarter received payments over $5,000 that were not related to research.

  • READ >>

Optimal Treatment for Early-Stage Follicular Lymphoma Still Not Established

October 9, 2019
  • Leah Lawrence

The international retrospective study included 365 patients with newly diagnosed early-stage follicular lymphoma rigorously staged with PET-CT and bone marrow biopsy.

  • READ >>

Subcutaneous Rituximab Maintained Efficacy, Was Safe in DLBCL, FL

October 9, 2019
  • Leah Lawrence

Switching from intravenous to subcutaneous administration of rituximab for non-Hodgkin diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL) resulted in similar efficacy with no new safety issues.

  • READ >>

Social Media Recruiting for Trials Falls Short

October 8, 2019
  • Leah Lawrence

A survey of physicians found recruiting for trials through social media can be useful, but not for cancer therapeutic trials.

  • READ >>

Transplant Outcomes in Myeloma with Renal Insufficiency Improved

October 7, 2019
  • Leah Lawrence

Autologous stem cell transplant has become safer over the years for patients with multiple myeloma and renal insufficiency.

  • READ >>

Potency of CAR T-Cell Therapy for Myeloma May Vary by Disease Stage

October 7, 2019
  • Leah Lawrence

CAR T cells are a more effective therapy if manufactured for patients with multiple myeloma prior to the onset of relapsed or refractory disease.

  • READ >>

PD-L1 Inhibition Plus Pegilodecakin Active in Advanced Solid Tumor All-Comers

October 3, 2019
  • Leah Lawrence

A combination of pegilodecakin (pegylated IL-10) with an anti-PD-L1 monoclonal antibody inhibitor showed preliminary antitumor activity.

  • READ >>

Oncologists Responsive to FDA Label Restrictions

October 1, 2019
  • Leah Lawrence

After the FDA restricted the labels of 2 drugs used to treat bladder cancer, oncologists' use of these treatments decreased drastically.

  • READ >>

Pembrolizumab Plus Chemo Boosts Response in Triple-Negative Breast Cancer

September 30, 2019
  • Leah Lawrence

Adding the immunotherapy pembrolizumab to neoadjuvant chemotherapy improved the pathological complete response rate in patients with early triple-negative breast cancer, according to findings of a study presented at ESMO.

  • READ >>

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Breast Cancer
  • Acute Myeloid Leukemia
  • HER2-Positive Breast Cancer
  • Videos Breast Cancer
  • Follicular Lymphoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

ONCOLOGY Vol 33 No 11
Nov 21, 2019 Vol 33 No 11
Subscribe
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".